We have collected information about Solid Lipid Nanoparticles For Pulmonary Delivery for you. Follow the links to find out details on Solid Lipid Nanoparticles For Pulmonary Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747341/
Aug 01, 2013 · The main purpose of the present work was studying the biodistribution of amikacin solid lipid nanoparticles (SLNs) after pulmonary delivery to increase its concentration in the lungs for treatment of cystic fibrosis lung infections and also providing a new method for clinical application of amikacin.Author: J. Varshosaz, S. Ghaffari, S. F. Mirshojaei, A. Jafarian, F. Atyabi, F. Kobarfard, S. Azarmi
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013600/
Apr 08, 2014 · Colloidal drug delivery systems have been extensively investigated as drug carriers for the application of different drugs via different routes of administration. Systems, such as solid lipid nanoparticles, polymeric nanoparticles and liposomes, have been investigated for a long time for the treatment of various lung diseases.Author: Mukta Paranjpe, Christel C. Müller-Goymann
https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/solid-lipid-nanoparticle
Solid lipid nanoparticles are a new generation of colloidal drug carrier systems and consist of surfactant-stabilized lipids that are solid both at room and body temperatures [52].They combine the advantages of liposomes, polymeric nanoparticles, and emulsions while minimizing some of their individual disadvantages [53,54].They typically contain a hydrophobic solid matrix core with a ...
https://www.sciencedirect.com/science/article/pii/S0378517308000215
May 22, 2008 · Growing attention has been given to the potential of pulmonary route as an alternative for non-invasive systemic delivery of therapeutic agents. In this study, novel nebulizer-compatible solid lipid nanoparticles (SLNs) for pulmonary drug delivery of insulin were developed by reverse micelle-double emulsion method.Author: Jie Liu, Tao Gong, Hualin Fu, Changguang Wang, Xiuli Wang, Qian Chen, Qin Zhang, Qin He, Zhirong Zha...
https://www.hindawi.com/journals/bmri/2013/136859/
The main purpose of the present work was studying the biodistribution of amikacin solid lipid nanoparticles (SLNs) after pulmonary delivery to increase its concentration in the lungs for treatment of cystic fibrosis lung infections and also providing a new method for clinical application of amikacin. To achieve this aim, 99m Tc labelled amikacin was loaded in cholesterol SLNs and after <i>in ...Author: J. Varshosaz, S. Ghaffari, S. F. Mirshojaei, A. Jafarian, F. Atyabi, F. Kobarfard, S. Azarmi
https://www.researchgate.net/publication/5571325_Solid_lipid_nanoparticles_for_pulmonary_delivery_of_insulin
In this study, novel nebulizer-compatible solid lipid nanoparticles (SLNs) for pulmonary drug delivery of insulin were developed by reverse micelle-double emulsion method.
https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00169
Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration purposes, were developed through a technique that avoids the use of organic solvents or sonication. To facilitate their pulmonary delivery, the RFB-loaded SLN were included in microspheres of appropriate size using suitable excipients (mannitol and trehalose) through a spray-drying technique. Confocal ...Author: Diana P. Gaspar, Maria Manuela Gaspar, Carla V. Eleutério, Ana Grenha, Mateo Blanco, Lídia M. D. Gon...
Searching for Solid Lipid Nanoparticles For Pulmonary Delivery?
You can just click the links above. The data is collected for you.
